C4x Discry Hdgs Share News (C4XD)

IN BRIEF: C4X Discovery shareholders approve of taking firm private

C4X Discovery Holdings PLC - Manchester, England-based drug discovery company - Shareholders pass all resolutions at general meeting, including resolution one: to cancel the admission of shares to trading on AIM in London, effective from the opening bell on Friday next week. Resolution one passes with 93% voting in favour and 6.9% voting against. Resolution two passes by a similar margin, meaning shareholders approve of C4X re-registering as a private limited company with the name C4X Discovery Holdings Ltd. This is expected to take place in the week beginning April 29.

UK shareholder meetings calendar - next 7 days

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

UK shareholder meetings calendar - next 7 days

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

C4X Discovery receives $11m from AstraZeneca for COPD drug progress

(Sharecast News) - C4X Discovery, the AIM-listed drug discovery company, has received a "milestone payment" of $11m from biopharma giant AstraZeneca as part of the progress of its NRF2 Activator programme, causing shares to jump by nearly a half on Wednesday.

C4X Discovery shares topple 10% as loss widens on higher costs

(Alliance News) - C4X Discovery Holdings PLC on Thursday reported a wider annual loss as costs rose and revenue fell.

UK earnings, trading statements calendar - next 7 days

TRADING UPDATES: C4X Discovery inks Indivior deal, Digitalbox expands

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

C4X Discovery chair steps down; Clive Dix named interim chair & CEO

(Alliance News) - C4X Discovery Holdings PLC said on Tuesday that Chair Eva-Lotta Allan will step down with immediate effect, and that Clive Dix will become interim executive chair & chief executive officer until a replacement is found.